Companies: 10,795·Total market cap: $144.5T
MiNK Therapeutics, Inc.

MiNK Therapeutics, Inc.

INKTNASDAQHealthcare● Active
$11.34
$-0.53(-4.47%)
Market Cap$56494735
P/E Ratio
52W High$76
52W Low$6.8
Overview

MiNK Therapeutics, Inc. (INKT) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · INKT · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-2.83inkt eps ttm · inkt earnings per shareEarnings history
PE Ratio (TTM)inkt pe ratio ttm · inkt price to earningsPE Ratio deep dive
Revenue (TTM)0.00inkt revenue ttm · inkt annual revenueFull revenue history
Dividend YieldNo Dividenddoes inkt pay dividends · inkt dividend yieldDividend history
Shares Outstanding4.3Minkt shares outstanding · inkt floatShares outstanding history
Next EarningsAug 13, 2026Est.inkt earnings date · inkt next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
mink therapeutics, inc. revenue · inkt revenue 2025
FY 2025Net Income-$12.5M▼ 15.85% YoY
202320242025
mink therapeutics, inc. net income · inkt profit 2025
FY 2025EPS$-2.93▼ 1.03% YoY
202320242025
inkt eps · mink therapeutics, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$12.5MEPS: $-2.83View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy5 analystsis inkt a buy · inkt analyst rating
Strong Buy
0
Buy
4
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$35.00Low
$11.34Current
$35.00Avg Target208.64% upside
$35.00High
inkt price target · inkt 12 month forecast

Total: 5 · Buy rate: 80.0%

The INKT analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $35.00, representing +208.64% upside from the current price of $11.34.

Stock Performance

Full History
1D-4.47%
1W-5.26%
1M+2.72%
3M+10.31%
YTD+1.70%
1Y+58.38%
5Y-90.55%

About MiNK Therapeutics, Inc.

CEOJennifer S. Buell
IPO DateOct 15, 2021
Employees23
CountryUS

MiNK Therapeutics, Inc. is a biopharmaceutical firm currently undergoing clinical trials. Its primary focus is on the identification, advancement, and market introduction of innovative invariant natur…

what is mink therapeutics, inc. · inkt stock overview · mink therapeutics, inc. company profile · who is mink therapeutics, inc. ceo · inkt NASDAQ · mink therapeutics, inc. headquarters · mink therapeutics, inc. business segments

About Stock Overview & Key Data

MiNK Therapeutics, Inc. (INKT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 15, 2021. As of the latest trading session, INKT stock price is $11.34, with a market capitalization of $56.5M. The stock has returned +58.38% over the past 12 months and +1.70% year-to-date.

According to 5 Wall Street analysts, the consensus rating for MiNK Therapeutics, Inc. stock is Buy, with an average 12-month price target of $35.00. In fiscal year 2025, MiNK Therapeutics, Inc. reported revenue of — and net income of -$12.5M. For detailed data — including MiNK Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, MiNK Therapeutics, Inc. (INKT) stock price is $11.34. The stock is traded on NASDAQ under the ticker symbol INKT. The 52-week range is $6.80 – $76.00.

INKT stock priceINKT quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice